Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on January 13, 2006, covering events occurring on January 10, 2006. The filing addresses corporate governance matters, specifically the approval of the 2006 compensation program for independent directors and the departure of a director.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on non-financial corporate governance items.
Material Changes
- Director Compensation: The Board approved the 2006 compensation package for independent directors, which remains unchanged from the 2005 structure.
- Director Departure: Louis V. Gerstner, Jr. notified the Company on January 10, 2006, that he will not stand for re-election to the Board of Directors at the 2006 Annual Meeting of Stockholders.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. It details the specific terms of the director compensation program:
- Annual Retainer: $45,000, with 25% required to be deferred into a BMS Stock account until ownership guidelines are met.
- Meeting Fees: $2,000 per Board, Committee, or Annual Meeting attended.
- Committee Chair Fees: $10,000 annual fee for Chairs of the Audit, Compensation and Management Development, and Directors and Corporate Governance Committees.
- Equity Awards: 2,000 deferred common share units annually and an option to purchase 2,500 shares of BMS Stock granted at the Annual Meeting (exercisable in four equal installments).
- Charitable Program: Directors participate in a program funded by company-purchased life insurance policies providing a $1 million death benefit, split equally between a charity designated by the director and the Bristol-Myers Squibb Foundation.
Investor Verification Checklist
- Verify the exact date of the 2006 Annual Meeting of Stockholders to confirm the timing of the director election and option grants.
- Confirm the total number of independent directors to calculate the aggregate cost of the approved compensation program.
- Review the company's proxy statement for the 2006 Annual Meeting to see the final slate of director nominees following Louis V. Gerstner, Jr.'s departure.
- Check subsequent filings for any changes to the deferred compensation plan or stock option vesting schedules.